Namita Goyal

7PUBLICATIONS
44CO-AUTHORS
Medical virologyPeripheral nervous systemEpidemiological methodsHaematological tumoursCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 06, 2026
A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Nicol C Voermans, Jeffrey M Statland, Lawrence J Hayward

|Dec 30, 2025
Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS.

Namita A Goyal, Jinsy A Andrews, Björn E Oskarsson

|Aug 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis.

Brooke Krivickas, Erica Scirocco, Elisa Giacomelli

|Oct 31, 2024
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.

Steven Perrin, Shafeeq Ladha, Nicholas Maragakis

|Oct 26, 2024
The Effectiveness of NP001 on the Long-Term Survival of Patients with Amyotrophic Lateral Sclerosis.

Bruce D Forrest, Namita A Goyal, Thomas R Fleming

|Aug 01, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms.

Lisa Christopher-Stine, Anna Ciesluk, Hector Chinoy

Pageof 2

Frequent Collaborators

2 joint publications

Paige M Bracci

2 joint publications

Sabrina Paganoni

2 joint publications

Michael Rivner

1 joint publications

Lisa Christopher-Stine